Trade

with

BSD Medical Corp
(NASDAQ: BSDM)
AdChoices
0.5400
+0.0096
+1.81%
After Hours :
-
-
-

Open

0.5299

Previous Close

0.5304

Volume (Avg)

54.92k (107.64k)

Day's Range

0.4900-0.5400

52Wk Range

0.3620-1.78

Market Cap.

21.05M

Dividend Rate ( Yield )

-

Beta

0.59

Shares Outstanding

39.69M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 3.67M

    • Net Income

    • -8.25M

    • Market Cap.

    • 21.05M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -139.24

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.59

    • Forward P/E

    • -

    • Price/Sales

    • 3.50

    • Price/Book Value

    • 2.64

    • Price/Cash flow

    • -2.55

      • EBITDA

      • -8.14M

      • Return on Capital %

      • -56.31

      • Return on Equity %

      • -65.04

      • Return on Assets %

      • -56.31

      • Book Value/Share

      • 0.20

      • Shares Outstanding

      • 39.69M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -4.80

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • -6.51

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 42.52

            • 64.08

            • Pre-Tax Margin

            • -139.20

            • 15.19

            • Net Profit Margin

            • -139.24

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 31.90

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -321.80

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -315.20

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 5.34

              • 2.55

              • Quick Ratio

              • 3.76

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.19

              • 1.86

              • Book Value/Share

              • 0.20

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.99

                • 34.01

                • P/E Ratio 5-Year High

                • -35.08

                • 224.03

                • P/E Ratio 5-Year Low

                • -1.94

                • 60.23

                • Price/Sales Ratio

                • 2.77

                • 3.17

                • Price/Book Value

                • 2.09

                • 3.20

                • Price/Cash Flow Ratio

                • -2.55

                • 18.42

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -65.04

                        (-54.30)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -56.31

                        (-50.70)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -64.70

                        (-54.30)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 1.30

                      • 2.77

                      • Asset Turnover

                      • 0.40

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -8.27M
                      Operating Margin
                      -225.23
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -2.55
                      Ownership

                      Institutional Ownership

                      9.39%

                      Top 10 Institutions

                      10.55%

                      Mutual Fund Ownership

                      3.20%

                      Float

                      79.32%

                      5% / Insider Ownership

                      18.89%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        346,683

                      • 0.00

                      • 0.87

                      • Vanguard Extended Market Index Fund

                      •  

                        293,101

                      • 0.00

                      • 0.74

                      • DFA U.S. Micro Cap Portfolio

                      •  

                        161,152

                      • 0.00

                      • 0.41

                      • Vanguard Instl Total Stock Market Index

                      •  

                        102,783

                      • 0.00

                      • 0.26

                      • iShares Micro-Cap

                      •  

                        96,427

                      • 1.28

                      • 0.19

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        95,648

                      • 0.00

                      • 0.24

                      • DFA U.S. Small Cap Portfolio

                      •  

                        56,629

                      • 0.00

                      • 0.14

                      • Fidelity Spartan® Total Market Idx Fund

                      •  

                        46,363

                      • 0.00

                      • 0.12

                      • EB DL Non-SL Market Completion Fund

                      •  

                        39,223

                      • 650.11

                      • 0.11

                      • Vanguard Balanced Index Fund

                      •  

                        12,439

                      • -11.40

                      • 0.03

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        750,864

                      • +11.71%

                      • 2.20

                      • Dimensional Fund Advisors, Inc.

                      •  

                        281,966

                      • -1.45%

                      • 0.82

                      • Geode Capital Management, LLC

                      •  

                        142,011

                      • 0.00%

                      • 0.41

                      • BlackRock Fund Advisors

                      •  

                        102,125

                      • +2.94%

                      • 0.30

                      • Texas Capital Bancshares Inc

                      •  

                        78,470

                      • 0.00%

                      • 0.20

                      • California Public Employees Retrmnt Sys

                      •  

                        59,643

                      • 0.00%

                      • 0.17

                      • Northern Trust Investments, N.A.

                      •  

                        55,046

                      • 0.00%

                      • 0.16

                      • Oppenheimer & Co. Inc.

                      •  

                        46,443

                      • +16.15%

                      • 0.14

                      • BNY Mellon Asset Management Ltd.

                      •  

                        45,884

                      • 0.00%

                      • 0.13

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Distressed

                      Style

                      Small Growth

                      BSD Medical Corp was originally incorporated under the laws of the State of Utah on March 17, 1978. On July 3, 1986, the Company was reincorporated in the State of Delaware The Company develops, manufactures, market and services syst...moreems to treat cancer and benign diseases using heat therapy delivered using focused radiofrequency (RF) and microwave energy. Its product line for cancer therapy has been created to offer hospitals and clinics a complete solution for thermal treatment of cancer using microwave/RF systems. Microwave ablation system is used to ablate (destroy) soft tissue with heat alone. Thermal ablation is used to destroy local tumors using a short intense focus of heat on a specific area, which is usually small, similar to surgical removal of the tumor. Its product line includes systems ...morethat have been strategically designed to offer a range of thermal treatment systems for the treatment of cancer, including both hyperthermia and ablation treatment systems. Current and future cancer treatment sites for its systems may include cancers of the prostate, breast, head, neck, bladder, cervix, colon/rectum, ovaries, esophagus, liver, kidney, brain, bone, stomach and lung. The BSD-500 comes in several versions, depending on the customer requirements. The BSD-2000 Hyperthermia System, or the BSD-2000, family of products includes the BSD-2000, the BSD-2000/3D and the BSD-2000/3D/MR. These systems non-invasively deliver localized therapeutic heating (hyperthermia) to solid tumors by applying radiofrequency (RF) energy to certain cancerous tumors, including those located deep within the body. These systems consist of four major subsystems: an RF power generator delivery subsystem; a proprietary, thermistor-based, thermometry subsystem; a computerized monitoring and control subsystem; and an applicator subsystem that includes an applicator and patient support system; as well as various accessories. As a further enhancement of the BSD-2000/3D, it has added to it the option of concurrent magnetic resonance imaging, or MRI, used for non-invasively monitoring the tissue temperatures during delivery of deep hyperthermia therapy. Its target customers include clinics, hospitals and institutions in which cancer is treated, located either in the United States or international markets. The company generally provides a 12-month warranty and record a liability for the warranty following installation on all cancer treatment systems and a 90-day limited warranty on individual components. Competitors in the thermal ablation market include RadioTherapeutics, a division of Boston Scientific Corporation, Covidien Ltd., Angiodynamics, Inc. and Microsulis Medical Ltd. The medical devices that it has developed and is developing are subject to extensive and rigorous regulation by numerous governmental authorities, principally by the FDA, and comparable foreign agencies.lessless

                      Key People

                      Harold R. Wolcott

                      CEO/Director/President

                      Mr. Timothy C. Mcquay

                      Chairman of the Board/Director

                      William S. Barth

                      CFO/Chief Accounting Officer/Secretary

                      Dixie Toolson Sells

                      Vice President, Divisional

                      Mr. Todd H. Turnlund

                      Vice President, Divisional

                      • BSD Medical Corp

                      • 2188 West 2200 South

                      • Salt Lake City, UT 84119

                      • USA.Map

                      • Phone: +1 801 972-5555

                      • Fax: +1 801 972-5930

                      • bsdmc.com

                      Incorporated

                      1978

                      Employees

                      48

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: